Spago Nanomedical Valuation
| SPAGO Stock | SEK 0.20 0.01 4.76% |
Spago Nanomedical seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of Spago Nanomedical from inspecting the company fundamentals such as Current Valuation of (13.94 M), return on equity of -0.21, and Price To Sales of 9.48 X as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Spago Nanomedical's price fluctuation is out of control at this time. Calculation of the real value of Spago Nanomedical is based on 3 months time horizon. Increasing Spago Nanomedical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Spago stock is determined by what a typical buyer is willing to pay for full or partial control of Spago Nanomedical AB. Since Spago Nanomedical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Spago Stock. However, Spago Nanomedical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.2 | Real 0.17 | Hype 0.2 | Naive 0.2 |
The intrinsic value of Spago Nanomedical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Spago Nanomedical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Spago Nanomedical AB helps investors to forecast how Spago stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Spago Nanomedical more accurately as focusing exclusively on Spago Nanomedical's fundamentals will not take into account other important factors: Spago Nanomedical Total Value Analysis
Spago Nanomedical AB is at this time projected to have takeover price of (13.94 M) with market capitalization of 72.75 M, debt of 0, and cash on hands of 76.87 M. The negative valuation of Spago Nanomedical may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should thoroughly investigate all of the Spago Nanomedical fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(13.94 M) | 72.75 M | 0 | 76.87 M |
Spago Nanomedical Investor Information
About 26.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.28. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Spago Nanomedical recorded a loss per share of 1.04. The entity had not issued any dividends in recent years. The firm had 369:364 split on the 8th of June 2022. Spago Nanomedical AB is not in a good financial situation at the moment. It has a very high risk of going through financial straits in February.Spago Nanomedical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Spago Nanomedical has an asset utilization ratio of 0.34 percent. This implies that the Company is making kr0.003444 for each dollar of assets. An increasing asset utilization means that Spago Nanomedical AB is more efficient with each dollar of assets it utilizes for everyday operations.Spago Nanomedical Ownership Allocation
Spago Nanomedical shows a total of 90.94 Million outstanding shares. Spago Nanomedical maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Spago Nanomedical Profitability Analysis
The company reported the revenue of 660 K. Net Loss for the year was (39.07 M) with loss before overhead, payroll, taxes, and interest of (13.89 M).About Spago Nanomedical Valuation
The stock valuation mechanism determines Spago Nanomedical's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Spago Nanomedical based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Spago Nanomedical. We calculate exposure to Spago Nanomedical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Spago Nanomedical's related companies.Spago Nanomedical AB develops nanomaterials for cancer diagnostics and treatment. Spago Nanomedical AB was founded in 2007 and is based in Lund, Sweden. Spago Nanomedical is traded on Stockholm Stock Exchange in Sweden.
8 Steps to conduct Spago Nanomedical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Spago Nanomedical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Spago Nanomedical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Spago Nanomedical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Spago Nanomedical's revenue streams: Identify Spago Nanomedical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Spago Nanomedical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Spago Nanomedical's growth potential: Evaluate Spago Nanomedical's management, business model, and growth potential.
- Determine Spago Nanomedical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Spago Nanomedical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Spago Stock Analysis
When running Spago Nanomedical's price analysis, check to measure Spago Nanomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spago Nanomedical is operating at the current time. Most of Spago Nanomedical's value examination focuses on studying past and present price action to predict the probability of Spago Nanomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spago Nanomedical's price. Additionally, you may evaluate how the addition of Spago Nanomedical to your portfolios can decrease your overall portfolio volatility.